ScopusElsevier Scopus
Status
Active
Coverage
2016–2026
Source type
Journal
Open access
Yes
CiteScore
5
Best quartile
Q2 · 63rd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 158 / 428 | 63rd | Q2 |
| Cancer Research | 128 / 233 | 45th | Q3 |
Cancer Treatment and Research Communications
ISSN 2468-2942
Publisher: Elsevier Ltd
Scopus · Q2WoS · ESCIOpen AccessONOS
Is Cancer Treatment and Research Communications indexed in Scopus? Yes — actively indexed in Scopus, coverage 2016–2026, best quartile Q2, CiteScore 5.
Is Cancer Treatment and Research Communications in Web of Science? Yes — indexed in the Emerging Sources Citation Index.
Is Cancer Treatment and Research Communications open access? Yes — it is an open-access journal, listed in DOAJ.
5
CiteScore 2025
Scopus
Q2
Best quartile
63rd percentile
3
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.